TRIANGLE INSIGHTS GROUP BY MERCALIS STRENGTHENS TEAM WITH HIRING OF NEW PARTNER
Premier life sciences consulting firm welcomes
The hiring of Greeby further strengthens Triangle's senior leadership team. She is a seasoned commercial executive with extensive progressive US and global leadership expertise in complex, competitive therapeutic areas inclusive of oncology, hematology, rare disease, and metabolic disorders. Prior to joining Triangle, Greeby most recently served as SVP, Launch Excellence at Precision AQ and VP, Global and US Marketing, Business Analytics, and New Product Planning for Athenex Oncology. Earlier commercial leadership roles include VP of Global Product Strategy at Shire and Head of US Metabolics Marketing with Takeda.
Greeby possesses proven expertise in strategic franchise planning and execution with a focus on P&L growth across all stages of the product life cycle. She has extensive Market Access experience, both on the industry and consulting sides, which will bolster Triangle's growing expertise within its Pricing and Market Access division.
Greeby holds a BS in Industrial Engineering with a focus on Polymer Chemistry from the University of Cincinnati and an MBA with an emphasis on Marketing and Strategy from the University of Michigan's Stephen M. Ross School of Business.
"Jennifer is an extremely valuable addition to our team," said
To learn more about Triangle Insights Group by Mercalis, please visit https://triangleinsightsgroup.com.
About Triangle Insights Group
Triangle Insights Group is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. The firm's approach combines deep industry knowledge with strong analytical rigor to drive strategic decision-making across client domains. Triangle's expertise encompasses key therapeutic areas (oncology, CNS, and cell and gene therapy) and relevant industry disciplines (pricing and market access, new product planning, and commercial strategy). For more information, visit https://triangleinsightsgroup.com.
About Mercalis
Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Above all, Mercalis helps navigate the complex life sciences marketplace to accelerate value and enhance patient lives. Founded in 2000, Mercalis provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in
Contact:
VP, Marketing & Communications
TrialCard Incorporated
[email protected]
View original content:https://www.prnewswire.com/news-releases/triangle-insights-group-by-mercalis-strengthens-team-with-hiring-of-new-partner-302361905.html
SOURCE Mercalis
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OCI N.V. statement on NNS
- DEEP Robotics Hosts Global Partner Conference, Unveiling "1+X+N" Strategy to Accelerate Commercial Embodied AI Worldwide
- Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Trian FundSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share